Company intelligence / Profile preview

HoustonPharma

Houston, Texas, United States

Ownership: Private
Development stage: Other

Overview

Houston Pharma is a specialty pharmaceutical company focused on the development and commercialization of innovative products for the treatment of Central Nervous System (CNS) disorders and pain management. The company leverages proprietary drug delivery technologies to improve the efficacy and safety profiles of established therapeutic agents. Its lead development programs include HP-101, a novel formulation targeting Attention Deficit Hyperactivity Disorder (ADHD), and HP-201 for pain indications. Houston Pharma aims to address unmet medical needs by providing optimized treatment options for patients with chronic neurological and pain-related conditions.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on HoustonPharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HoustonPharma.

Explore the full profile